Patents by Inventor LI-YU SUNG

LI-YU SUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9988637
    Abstract: A Cas9 expression plasmid, a genome editing system and a genome editing method for Escherichia coli are provided. The Cas9 expression plasmid includes a tracrRNA sequence, a Cas9 gene and a chloramphenicol resistance gene (CmR). The Cas9 expression plasmid is applied to CRISPR/Cas-coupled ?-red recombineering system for editing genomes of E. coli with high efficiency.
    Type: Grant
    Filed: April 24, 2017
    Date of Patent: June 5, 2018
    Assignees: NATIONAL TSING HUA UNIVERISTY, CHANG CHUN PLASTICS CO., LTD, CHANG CHUN PETROCHEMICAL CO., LTD
    Inventors: Yu Chen Hu, Mu-En Chung, I-Hsin Yeh, Hung Li, Li-Yu Sung
  • Publication number: 20180037887
    Abstract: The present disclosure relates to a gene expression regulation system of a Synechococcus elongatus PCC 7942. The gene expression regulation system of the S. elongatus PCC 7942 includes a S. elongatus PCC 7942 cell, a gene expression interference unit and a gene editing unit. The present disclosure also relates to a method for regulating a gene expression of the S. elongatus PCC 7942. The method includes providing the S. elongatus PCC 7942 cell, using the gene editing unit to insert an exogenous gene into the S. elongates PCC 7942 cell, and using the gene expression interference unit to inhibit an expression of a target gene.
    Type: Application
    Filed: March 31, 2017
    Publication date: February 8, 2018
    Inventors: Yu-Chen HU, Hung LI, Chun-Hung HUANG, Li-Yu SUNG, Chih-Che SHEN
  • Publication number: 20170226522
    Abstract: A Cas9 expression plasmid, a genome editing system and a genome editing method for Escherichia coli are provided. The Cas9 expression plasmid includes a tracrRNA sequence, a Cas9 gene and a chloramphenicol resistance gene (CmR). The Cas9 expression plasmid is applied to CRISPR/Cas-coulped ?-red recombineering system for editing genomes of E. coli with high efficiency.
    Type: Application
    Filed: April 24, 2017
    Publication date: August 10, 2017
    Inventors: YU CHEN HU, MU-EN CHUNG, I-HSIN YEH, HUNG LI, LI-YU SUNG